HeNan Splendor Science & Technology Co Accounts Payable
The Accounts Payable of HeNan Splendor Science & Technology Co (002296.SZ) as of Oct 8, 2026 is 449.47 M CNY. In the previous year, Accounts Payable was 448.45 M CNY — a change of 0.23% (higher).
Get this data via API
Financial Data API
Accounts Payable
449.47 MCNY
YoY
0.23%
Last updated:
The HeNan Splendor Science & Technology Co Accounts Payable history
3 Years
10 Years
25 Years
Max
| YEAR | Accounts Payable | YoY |
|---|---|---|
| 449.47 MCNY | +0.23% | |
| 448.45 MCNY | +96.49% | |
| 228.23 MCNY | -10.33% | |
| 254.52 MCNY | +32.42% | |
| 192.21 MCNY | -13.56% | |
| 222.36 MCNY | +37.89% | |
| 161.25 MCNY | -7.66% | |
| 174.62 MCNY | -16.25% | |
| 208.50 MCNY | +1.55% | |
| 205.32 MCNY | -7.26% | |
| 221.39 MCNY | +12.87% | |
| 196.15 MCNY | — |
HeNan Splendor Science & Technology Co Stock analysis
Frequently Asked Questions about HeNan Splendor Science & Technology Co stock
Accounts Payable of HeNan Splendor Science & Technology Co is 449.47 M CNY in 2025.
Accounts Payable of HeNan Splendor Science & Technology Co changed from 448.45 M CNY to 449.47 M CNY, representing a 0.23% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Accounts Payable HeNan Splendor Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.
Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.
Accounts Payable's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's HeNan Splendor Science & Technology Co historically and in real time.
Balance Sheet — HeNan Splendor Science & Technology Co
All Key Metrics — HeNan Splendor Science & Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth